Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0000950170-25-061366

Chief Financial Officer sold 19,191 shares at an average $3.07 ($58,849)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Catinazzo Thomas · Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-04-28 Sale : show line 1 in the form 10b5-1 −1,709 $3.17 $5,418 372,858 D
2025-04-28 Sale : show line 2 in the form 10b5-1 −981 $3.17 $3,110 371,877 D
2025-04-29 Sale : show line 3 in the form 10b5-1 −3,558 $3.23 $11,492 368,319 D
2025-04-30 Sale : show line 4 in the form 10b5-1 −12,943 $3.00 $38,829 355,376 D
Open-market sales · 19,191 sh · avg $3.07 · $58,849
Loading xslF345X05/ownership.xml…